Assessment of Cost effectiveness of Alpelisib in Advanced Breast Cancer Patients
Latest Information Update: 24 Nov 2020
At a glance
- Drugs Alpelisib (Primary) ; Fulvestrant
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 24 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research